Notably, quantitative differences in specific sphingolipid species occurring after Enza treatment correlated with survival outcomes.<h4>Conclusions</h4>Plasma lipidomics reflects key metabolic features of PCa and is profoundly impacted by AR inhibition, with prognostic relevance in patients with mCRPC. This evidence concerns the gene AR and posterior cortical atrophy.